TCTR20230811008已完成2 期
Postpartum Severe Preeclampsia Maternal Outcomes In 12-Hours Versus 24-Hours Maintenance Doses of Magnesium Sulfate Administration: Randomized Control Trial
ocal, in Arifin Achmad Hospital0 个研究点目标入组 80 人开始时间: 2023年8月11日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 17 Years 至 43 Years（—）
- 性别
- Female
入选标准
- •All pregnant women diagnosed with severe preeclampsia who are eligible for magnesium sulfate administration get a loading dose of magnesium sulfate Zuspan. Postpartum severe preeclampsia mothers who received a maintenance dose of magnesium sulfate Zuspan.
排除标准
- •All severe preeclampsia patients with decreased consciousness; had complications such as eclampsia, HELLP syndrome, kidney failure, or acute pulmonary edema; were in labor; received antihypertensive therapy in the last 12 hours; had an allergy to the trial drugs; and had asthma and heart disease were excluded.
研究者
相似试验
已完成
不适用
Prediction of preeclampsia and adverse eventspreeclampsiatoxemia10026908NL-OMON48757eids Universitair Medisch Centrum400
招募中
不适用
Validation of the MaiRa Preeclampsia Test for Screening Early/Late Preeclampsia in First and Second TrimestersPreeclampsia (PE)NCT06716242iPremom7,473
Unknown
不适用
Maternal and Neonatal Outcome in Severe PreeclampsiaPre-EclampsiaNCT04126122Aljazeera Hospital100
已完成
不适用
First-trimester Prediction of PreeclampsiaPreeclampsiaSevere PreeclampsiaPreterm BirthFetal Growth RestrictionNCT02189148CHU de Quebec-Universite Laval7,554
撤回
不适用
Patient Satisfaction With Abbreviated Postpartum Magnesium Sulfate for Severe PreeclampsiaPatient SatisfactionNCT05789381University of Chicago